Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edge Therapeutics Inc (NASDAQ:EDGE)

10.77
Delayed Data
As of 4:00pm ET
 +0.31 / +2.96%
Today’s Change
7.30
Today|||52-Week Range
13.50
-13.84%
Year-to-Date
No recent news for Edge Therapeutics Inc.

Today’s Trading

Previous close10.46
Today’s open10.50
Day’s range10.32 - 10.89
Volume58,675
Average volume (3 months)72,013
Market cap$322.7M
Dividend yield--
Data as of 4:00pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)+66.58%
Earnings growth (this year)-39.30%
Earnings growth (next 5 years)+86.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.07-1.62%
BTXBioTime Inc-0.05-1.89%
GERNGeron Corp-0.02-0.98%
BLCMBellicum Pharmaceuti...-0.22-2.12%
Data as of 4:09pm ET, 10/23/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$0.00
Annual profit (last year)-$38.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Brian A. Leuthner
Chief Operating Officer
Daniel Brennan
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts